399 related articles for article (PubMed ID: 34264514)
1. Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine.
Waqar SHB; Khan AA; Memon S
Int J Hematol; 2021 Nov; 114(5):626-629. PubMed ID: 34264514
[TBL] [Abstract][Full Text] [Related]
2. Acquired Thrombotic Thrombocytopenic Purpura After BNT162b2 COVID-19 Vaccine: Case Report and Literature Review.
Hammami E; Lamarque M; Aujoulat O; Debliquis A; Drénou B; Harzallah I
Lab Med; 2022 Nov; 53(6):e145-e148. PubMed ID: 35482291
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases.
Saluja P; Gautam N; Yadala S; Venkata AN
Thromb Res; 2022 Jun; 214():115-121. PubMed ID: 35533526
[TBL] [Abstract][Full Text] [Related]
4. Acquired Thrombotic Thrombocytopenic Purpura Following BNT162b2 mRNA Coronavirus Disease Vaccination in a Japanese Patient.
Yoshida K; Sakaki A; Matsuyama Y; Mushino T; Matsumoto M; Sonoki T; Tamura S
Intern Med; 2022 Feb; 61(3):407-412. PubMed ID: 34803105
[TBL] [Abstract][Full Text] [Related]
5. First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report.
Osmanodja B; Schreiber A; Schrezenmeier E; Seelow E
BMC Nephrol; 2021 Dec; 22(1):411. PubMed ID: 34895163
[TBL] [Abstract][Full Text] [Related]
6. Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine.
Maayan H; Kirgner I; Gutwein O; Herzog-Tzarfati K; Rahimi-Levene N; Koren-Michowitz M; Blickstein D
J Thromb Haemost; 2021 Sep; 19(9):2314-2317. PubMed ID: 34105247
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 vaccine (mRNA BNT162b2) and COVID-19 infection-induced thrombotic thrombocytopenic purpura in adolescents.
Vorster L; Kirk SE; Muscal E; Despotovic JM; Cohen CT; Sartain SE
Pediatr Blood Cancer; 2022 Jun; 69(6):e29681. PubMed ID: 35373880
[TBL] [Abstract][Full Text] [Related]
8. Relapse of immune thrombotic thrombocytopenic purpura (iTTP) possibly triggered by COVID-19 vaccination and/or concurrent COVID-19 infection.
Fang F; Tse B; Pavenski K
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35902184
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.
Rizk JG; Gupta A; Sardar P; Henry BM; Lewin JC; Lippi G; Lavie CJ
JAMA Cardiol; 2021 Dec; 6(12):1451-1460. PubMed ID: 34374713
[TBL] [Abstract][Full Text] [Related]
10. Thrombotic thrombocytopenic purpura developed after pegylated interferon treatment for hepatitis B infection.
Mei S; Feng Y; Cui L; Chen J; Mao Z; Zhao X; Mei C; Qian Y
BMC Nephrol; 2022 Dec; 23(1):400. PubMed ID: 36513992
[TBL] [Abstract][Full Text] [Related]
11. Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine.
Giuffrida G; Condorelli A; Di Giorgio MA; Markovic U; Sciortino R; Nicolosi D; Di Raimondo F
Haematologica; 2022 Apr; 107(4):1008-1010. PubMed ID: 34382388
[No Abstract] [Full Text] [Related]
12. Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine.
Ruhe J; Schnetzke U; Kentouche K; Prims F; Baier M; Herfurth K; Schlosser M; Busch M; Hochhaus A; Wolf G
Ann Hematol; 2022 Mar; 101(3):717-719. PubMed ID: 34309715
[No Abstract] [Full Text] [Related]
13. Thrombotic thrombocytopenic purpura following administration of the Moderna booster vaccine.
Herrman E; Ghimire B; Chisti MM
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35332007
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic thrombocytopenic purpura developed during the conservative treatment of anti-phospholipase A
Iio R; Akiyama S; Mitsumoto K; Iwata Y; Okushima H; Shimada K; Ota N; Tomida K; Fushimi H; Shoji T; Matsumoto M; Hayashi T
BMC Nephrol; 2020 Oct; 21(1):431. PubMed ID: 33046023
[TBL] [Abstract][Full Text] [Related]
15. COVID 19 infection associated with thrombotic thrombocytopenic purpura.
Dhingra G; Maji M; Mandal S; Vaniyath S; Negi G; Nath UK
J Thromb Thrombolysis; 2021 Aug; 52(2):504-507. PubMed ID: 33904053
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 associated thrombotic thrombocytopenic purpura (TTP) ; A case series and mini-review.
Tehrani HA; Darnahal M; Vaezi M; Haghighi S
Int Immunopharmacol; 2021 Apr; 93():107397. PubMed ID: 33524803
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S Vaccination.
Yocum A; Simon EL
Am J Emerg Med; 2021 Nov; 49():441.e3-441.e4. PubMed ID: 33980419
[TBL] [Abstract][Full Text] [Related]
18. An Early Unexpected Immune Thrombotic Thrombocytopenic Purpura Relapse Associated with SARS-CoV-2 Infection: A Case Report and Literature Review.
Kornowski Cohen M; Sheena L; Shafir Y; Yahalom V; Gafter-Gvili A; Spectre G
Acta Haematol; 2021; 144(6):678-682. PubMed ID: 33895748
[TBL] [Abstract][Full Text] [Related]
19. Recurrence of Thrombotic Thrombocytopenic Purpura After Vaccination with mRNA-1273 COVID-19 vaccine.
Ntelis S; Champ K
J Community Hosp Intern Med Perspect; 2022; 12(4):80-84. PubMed ID: 36262899
[TBL] [Abstract][Full Text] [Related]
20. [Thrombotic thrombocytopenic purpura after circumcision].
Schott F; Gross AJ; Netsch C; Segerer S
Urologe A; 2017 Mar; 56(3):361-363. PubMed ID: 27272154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
